Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
Clinical trial NCT06980532 · RECRUITING
Trial details
- NCT number
- NCT06980532
- Sponsor
- Liu Huang
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-25
- Primary completion
- 2028-12-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.